Liquid biopsy under the spotlight on May 22 in Milan during the Symposium “mCRC – Comprendere l’eterogeneità e l’evoluzione del carcinoma colorettale metastatico: dai meccanismi alle terapie”
The first six patients have been enrolled in the Sagittarius clinical trial.
On the 12th of September, SAGITTARIUS experts joined the first Annual Cluster Meeting of the EU Cancer Mission “Diagnosis and Treatment” Cluster.
From September 13th to September 17th, many SAGITTARIUS partners and experts attended and participated in the European Society for Medical Oncology Congress (ESMO 2024).
On September 14, major advancements in understanding the biology of colon cancer in patients from the PEGASUS study were presented at the European Society for Medical Oncology (ESMO 2024).
Towards a precision medicine approach for colon cancer care
Promising preliminary results illustrated at the ESMO congress 2023
IFOM ETS – the AIRC Institute of Molecular Oncology, in Milan, hosted the official kick-off of SAGITTARIUS, a new precision oncology project, funded by the European Union under the Horizon Europe program.
